Author:
Tashkin Donald P.,Goodin Thomas,Bowling Alyssa,Price Barry,Ozol-Godfrey Ayca,Sharma Sanjay,Sanjar Shahin
Funder
Sunovion Pharmaceuticals Inc.
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD, 2019.
http://goldcopd.org/
.
2. Diaz-Guzman E, Mannino DM. Epidemiology and prevalence of chronic obstructive pulmonary disease. Clin Chest Med. 2014;35:7–16.
3. Postma DS, Bush A, van den Berge M. Risk factors and early origins of chronic obstructive pulmonary disease. Lancet. 2015;385:899–909.
4. Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389:1931–40.
5. Lundback B, Lindberg A, Lindstrom M, Ronmark E, Jonsson AC, Jonsson E, Larsson LG, Andersson S, Sandstrom T, Larsson K. Obstructive lung disease in northern Sweden S: not 15 but 50% of smokers develop COPD?--report from the obstructive lung disease in northern Sweden studies. Respir Med. 2003;97:115–22.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献